A detailed history of Keybank National Association transactions in Pfizer Inc stock. As of the latest transaction made, Keybank National Association holds 2,007,258 shares of PFE stock, worth $55.9 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
2,007,258
Previous 2,183,953 8.09%
Holding current value
$55.9 Million
Previous $62.9 Million 11.41%
% of portfolio
0.23%
Previous 0.28%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $4.57 Million - $5.25 Million
-176,695 Reduced 8.09%
2,007,258 $55.7 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $3.43 Million - $4.46 Million
-131,282 Reduced 5.67%
2,183,953 $62.9 Million
Q3 2023

Nov 08, 2023

SELL
$32.09 - $37.51 $2.52 Million - $2.95 Million
-78,621 Reduced 3.28%
2,315,235 $76.8 Million
Q2 2023

Aug 01, 2023

SELL
$36.12 - $41.79 $4.62 Million - $5.35 Million
-128,011 Reduced 5.08%
2,393,856 $87.8 Million
Q1 2023

May 10, 2023

SELL
$39.39 - $51.28 $5.19 Million - $6.76 Million
-131,854 Reduced 4.97%
2,521,867 $103 Million
Q4 2022

Jan 31, 2023

SELL
$41.75 - $54.5 $1.73 Million - $2.26 Million
-41,391 Reduced 1.54%
2,653,721 $136 Million
Q3 2022

Oct 27, 2022

SELL
$43.76 - $53.42 $915,853 - $1.12 Million
-20,929 Reduced 0.77%
2,695,112 $118 Million
Q2 2022

Aug 08, 2022

SELL
$46.53 - $55.17 $1.98 Million - $2.34 Million
-42,486 Reduced 1.54%
2,716,041 $142 Million
Q1 2022

Apr 28, 2022

SELL
$45.75 - $56.69 $2.48 Million - $3.07 Million
-54,162 Reduced 1.93%
2,758,527 $143 Million
Q4 2021

Feb 07, 2022

SELL
$41.32 - $61.25 $1.14 Million - $1.68 Million
-27,502 Reduced 0.97%
2,812,689 $166 Million
Q3 2021

Nov 08, 2021

SELL
$39.25 - $50.42 $1.39 Million - $1.79 Million
-35,419 Reduced 1.23%
2,840,191 $122 Million
Q2 2021

Aug 12, 2021

SELL
$35.91 - $40.68 $3.04 Million - $3.44 Million
-84,614 Reduced 2.86%
2,875,610 $113 Million
Q1 2021

May 07, 2021

SELL
$33.49 - $37.77 $4.34 Million - $4.89 Million
-129,548 Reduced 4.19%
2,960,224 $107 Million
Q4 2020

Feb 09, 2021

SELL
$33.47 - $42.56 $4.81 Million - $6.12 Million
-143,858 Reduced 4.45%
3,089,772 $114 Million
Q3 2020

Oct 29, 2020

SELL
$31.75 - $37.25 $5.22 Million - $6.13 Million
-164,447 Reduced 4.84%
3,233,630 $119 Million
Q2 2020

Aug 10, 2020

SELL
$30.12 - $36.54 $5.28 Million - $6.41 Million
-175,296 Reduced 4.91%
3,398,077 $111 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $7.36 Million - $10.5 Million
-272,387 Reduced 7.08%
3,573,373 $117 Million
Q4 2019

Feb 05, 2020

SELL
$32.92 - $37.36 $17.3 Million - $19.6 Million
-525,326 Reduced 12.02%
3,845,760 $151 Million
Q3 2019

Nov 04, 2019

SELL
$32.49 - $42.13 $1.15 Million - $1.49 Million
-35,313 Reduced 0.8%
4,371,086 $157 Million
Q2 2019

Aug 01, 2019

BUY
$36.98 - $41.52 $507,402 - $569,695
13,721 Added 0.31%
4,406,399 $191 Million
Q1 2019

May 08, 2019

BUY
$37.5 - $41.2 $988,837 - $1.09 Million
26,369 Added 0.6%
4,392,678 $187 Million
Q4 2018

Jan 30, 2019

SELL
$38.47 - $43.86 $155,726 - $177,545
-4,048 Reduced 0.09%
4,366,309 $191 Million
Q3 2018

Nov 08, 2018

BUY
$34.47 - $41.81 $41,846 - $50,757
1,214 Added 0.03%
4,370,357 $193 Million
Q2 2018

Aug 08, 2018

BUY
$32.98 - $35.16 $5.57 Million - $5.94 Million
169,015 Added 4.02%
4,369,143 $159 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $4.49 Million - $5.21 Million
140,635 Added 3.46%
4,200,128 $149 Million
Q4 2017

Feb 08, 2018

SELL
$33.26 - $35.29 $3.54 Million - $3.76 Million
-106,577 Reduced 2.56%
4,059,493 $147 Million
Q3 2017

Nov 02, 2017

SELL
$31.0 - $34.15 $1.38 Million - $1.52 Million
-44,625 Reduced 1.06%
4,166,070 $149 Million
Q2 2017

May 14, 2018

SELL
N/A
-77,314 Reduced 1.8%
4,210,695 $141 Million
Q1 2017

May 14, 2018

SELL
N/A
-55,335 Reduced 1.27%
4,288,009 $147 Million
Q4 2016

May 14, 2018

BUY
N/A
4,343,344
4,343,344 $141 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $156B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.